Evidence map›Paper›PMID 32399482›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation.

Christian R Salazar, Dan Hoang, Daniel L Gillen, Joshua D Grill

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Religious participation is associated with fewer dementia diagnoses among Black people in the United States.American journal of human biology : the official journal of the Human Biology Council · 2024
    Article
  13. Article
  14. Article
  15. Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  16. Atrophy links lower novelty-related locus coeruleus connectivity to cognitive decline in preclinical AD.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  17. Article
  18. Article
  19. Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial.The journal of prevention of Alzheimer's disease · 2024
    Article
  20. Leveraging African American family connectors for Alzheimer's disease genomic studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christian R SalazarUC Irvine Institute for Memory Impairments and Neurological Disorders University of California, Irvine Irvine California USA.
Dan HoangUC Irvine Institute for Memory Impairments and Neurological Disorders University of California, Irvine Irvine California USA.
Daniel L GillenUC Irvine Institute for Memory Impairments and Neurological Disorders University of California, Irvine Irvine California USA.
Joshua D GrillUC Irvine Institute for Memory Impairments and Neurological Disorders University of California, Irvine Irvine California USA.

Funding

UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Neuroimaging biomarkers for cognitive decline in elderly with amyloid pathologyR01AG053555 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Michael A Yassa · 2017 to 2026
$17.0M
Effects of Alzheimers Disease Clinical Trial Study Partners-Diversity SupplementRF1AG059407 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GILLEN, DANIEL L, GRILL, JOSHUA · 2018 to 2019
$1.6M
NCATS NIH HHS UL1 TR001414NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG053555NIA NIH HHS RF1 AG059407
6 · The paper itself

Abstract

introductionWe sought to examine the association of race/ethnicity with willingness to engage in studies that involve procedures typical of Alzheimer's disease (AD) clinical trials and determine whether any observed differences could be explained by research attitudes.

methodsWe studied 2749 adults aged ≥50 years who enrolled in a community-based recruitment registry.

resultsCompared to non-Hispanic (NH) whites (n = 2393, 87%), Hispanics (n = 191, 7%), NH Asians (n = 129, 5%) and NH blacks (n = 36, 1%) were 44%, 46%, and 64% less willing, respectively, to be contacted for studies that have requirements typical of AD prevention trials, namely: cognitive testing, brain imaging, blood draws, and investigational medications. Mediation by research attitudes was explored, but did not explain the observed differences. DISCUSSION: Our findings suggest that ethnoracial minorities are less willing to engage in studies that are typical of AD prevention trials. Future work should focus on understanding the factors that drive these differences.

Indexed as

Alzheimer's diseasebiomarker testingprevention trialsrace/ethnicityrecruitmentresearch attitudesresearch participation

Identifiers

PMID32399482
PMCPMC7207155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.